121 related articles for article (PubMed ID: 23751563)
21. [Influence of vascular comorbidities on the antioxidant defense system in Alzheimer's disease].
Polidori MC; Stahl W; De Spirt S; Pientka L
Dtsch Med Wochenschr; 2012 Feb; 137(7):305-8. PubMed ID: 22318842
[TBL] [Abstract][Full Text] [Related]
22. Serum ischaemia-modified albumin might be a potential biomarker for oxidative stress in amnestic mild cognitive impairment.
Du L; Ma J; He D; Zhang X
Psychogeriatrics; 2019 Mar; 19(2):150-156. PubMed ID: 30362220
[TBL] [Abstract][Full Text] [Related]
23. The relationship between diabetic retinopathy and serum levels of ischemia-modified albumin and malondialdehyde.
Turk A; Nuhoglu I; Mentese A; Karahan SC; Erdol H; Erem C
Retina; 2011 Mar; 31(3):602-8. PubMed ID: 21273947
[TBL] [Abstract][Full Text] [Related]
24. Serum levels of ischemia modified albumin in overweight/obese postmenopausal women: a potential biomarker of atherosclerotic burden associated with oxidative stress.
Kazanis K; Dalamaga M; Kassi E; Nounopoulos C; Manolis AS; Merantzi G; Jullien G; Dionyssiou-Asteriou A
Maturitas; 2011 Oct; 70(2):182-7. PubMed ID: 21839592
[TBL] [Abstract][Full Text] [Related]
25. Is the measurement of serum ischemia-modified albumin the best test to diagnose ovarian torsion?
Guven S; Kart C; Guvendag Guven ES; Cetin EC; Menteşe A
Gynecol Obstet Invest; 2015; 79(4):269-75. PubMed ID: 25591981
[TBL] [Abstract][Full Text] [Related]
26. Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia.
Cervellati C; Romani A; Seripa D; Cremonini E; Bosi C; Magon S; Passaro A; Bergamini CM; Pilotto A; Zuliani G
J Neurol Sci; 2014 Feb; 337(1-2):156-61. PubMed ID: 24321755
[TBL] [Abstract][Full Text] [Related]
27. Type 2 diabetes and/or its treatment leads to less cognitive impairment in Alzheimer's disease patients.
Domínguez RO; Marschoff ER; González SE; Repetto MG; Serra JA
Diabetes Res Clin Pract; 2012 Oct; 98(1):68-74. PubMed ID: 22658669
[TBL] [Abstract][Full Text] [Related]
28. Plasma and cerebrospinal fluid alpha1-antichymotrypsin levels in Alzheimer's disease: correlation with cognitive impairment.
DeKosky ST; Ikonomovic MD; Wang X; Farlow M; Wisniewski S; Lopez OL; Becker JT; Saxton J; Klunk WE; Sweet R; Kaufer DI; Kamboh MI
Ann Neurol; 2003 Jan; 53(1):81-90. PubMed ID: 12509851
[TBL] [Abstract][Full Text] [Related]
29. Serum ischemia-modified albumin levels in children with epileptic seizures.
Kocaoglu C; Caksen H; Atabek ME; Kurku H; Arslan S
Pediatr Emerg Care; 2014 Jun; 30(6):394-6. PubMed ID: 24849274
[TBL] [Abstract][Full Text] [Related]
30. Investigation of the possibility of using ischemia-modified albumin as a novel and early prognostic marker in cardiac arrest patients after cardiopulmonary resuscitation.
Turedi S; Gunduz A; Mentese A; Dasdibi B; Karahan SC; Sahin A; Tuten G; Kopuz M; Alver A
Resuscitation; 2009 Sep; 80(9):994-9. PubMed ID: 19581040
[TBL] [Abstract][Full Text] [Related]
31. Increased ischemia-modified albumin levels in patients with gastric cancer.
Fidan E; Mentese A; Kavgaci H; Orem A; Fidan S; Uzun A; Ozdemir F; Aydin F
Neoplasma; 2012; 59(4):393-7. PubMed ID: 22489694
[TBL] [Abstract][Full Text] [Related]
32. Elevated plasma endothelial microparticles in Alzheimer's disease.
Xue S; Cai X; Li W; Zhang Z; Dong W; Hui G
Dement Geriatr Cogn Disord; 2012; 34(3-4):174-80. PubMed ID: 23075931
[TBL] [Abstract][Full Text] [Related]
33. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
34. Plasma oxidative stress parameters in men and women with early stage Alzheimer type dementia.
Puertas MC; Martínez-Martos JM; Cobo MP; Carrera MP; Mayas MD; Ramírez-Expósito MJ
Exp Gerontol; 2012 Aug; 47(8):625-30. PubMed ID: 22664577
[TBL] [Abstract][Full Text] [Related]
35. Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study.
Tully AM; Roche HM; Doyle R; Fallon C; Bruce I; Lawlor B; Coakley D; Gibney MJ
Br J Nutr; 2003 Apr; 89(4):483-9. PubMed ID: 12654166
[TBL] [Abstract][Full Text] [Related]
36. [The clinical studies of hyperhomocysteinemia and Alzheimer's disease].
Li YL; Hou Y; Niu C; Yu LX; Cheng YY; Hong Y
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 Mar; 29(2):116-8, 127. PubMed ID: 23833960
[TBL] [Abstract][Full Text] [Related]
37. Gamma-glutamyltransferase and C-reactive protein in stable chronic obstructive pulmonary disease.
Biljak VR; Rumora L; Cepelak I; Pancirov D; Popović-Grle S; Sorić J; Stjepanović G; Grubisić TZ
Coll Antropol; 2013 Mar; 37(1):221-7. PubMed ID: 23697277
[TBL] [Abstract][Full Text] [Related]
38. The association between homocysteine (hcy) and serum natural antioxidants in elderly bone mineral densitometry (BMD).
Kuyumcu ME; Yesil Y; Oztürk ZA; Cınar E; Kızılarslanoglu C; Halil M; Ulger Z; Yesil NK; Cankurtaran M; Arıoğul S
Arch Gerontol Geriatr; 2012; 55(3):739-43. PubMed ID: 22682423
[TBL] [Abstract][Full Text] [Related]
39. Novel biochemical marker for differential diagnosis of seizure: ischemia-modified albumin.
Uzel M; Oray NC; Bayram B; Kume T; Girgin MC; Doylan O; Saritabak E; Yanturali S
Am J Emerg Med; 2014 Sep; 32(9):962-5. PubMed ID: 24997108
[TBL] [Abstract][Full Text] [Related]
40. Plasma gelsolin is decreased and correlates with rate of decline in Alzheimer's disease.
Güntert A; Campbell J; Saleem M; O'Brien DP; Thompson AJ; Byers HL; Ward MA; Lovestone S
J Alzheimers Dis; 2010; 21(2):585-96. PubMed ID: 20571216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
